MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphomaMichael A. Milhollen, Peter G. Smith, Tary Traore et al.|Blood|2010Cited by 323
Mortality among patients with ankylosing spondylitis after a single treatment course with x rays.Peter G. Smith, Richard Doll|BMJ|1982Cited by 231
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health OrganizationMinal Patel, Daniel R. Feikin, Isabel Bergeri et al.|Vaccine|2021Cited by 156
Overcoming Platinum Resistance in Preclinical Models of Ovarian Cancer Using the Neddylation Inhibitor MLN4924Amir A. Jazaeri, Anindya Dutta, Etsuko Shibata et al.|Molecular Cancer Therapeutics|2013Cited by 74
Setting research priorities to improve global newborn health and prevent stillbirths by 2025Vinod K Paul, Islam, Richard Luhanga et al.|UNC Libraries|2020Cited by 71